HH-120 Nasal Spray

DRUG4 trials

Sponsors

Beijing Ditan Hospital, Huahui Health

Conditions

COVID-19Coronavirus Disease 2019(COVID-19)SARS-CoV-2 Infection

Phase 2

A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19

CompletedNCT05713318

Huahui HealthCOVID-19

Start: 2023-01-18End: 2023-06-19Updated: 2024-10-10

Phase 3

HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

Enrolling by invitationNCT05787418

Huahui HealthCOVID-19

Start: 2023-03-31End: 2026-04-01Target: 1200Updated: 2024-10-10

Unknown Phase

A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients

CompletedNCT05659602

Beijing Ditan HospitalCoronavirus Disease 2019(COVID-19)

Start: 2022-07-09End: 2023-01-03Updated: 2024-10-10

A Study of HH-120 Nasal Spray in Close Contacts of Those Diagnosed With COVID-19

CompletedNCT05747677

Beijing Ditan HospitalCOVID-19, SARS-CoV-2 Infection

Start: 2022-06-14End: 2023-02-06Updated: 2023-02-28